OroMin (Germiphene Corporation)


Welcome to the PulseAid listing for the OroMin drug offered from Germiphene Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Germiphene Corporation
NON-PROPRIETARY NAME: calcium chloride, sodium fluoride, sodium phosphate
SUBSTANCE NAME: SODIUM PHOSPHATE, MONOBASIC; CALCIUM CHLORIDE; SODIUM FLUORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: DENTAL
DOSAGE FORM: RINSE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2017-06-16
END MARKETING DATE: 0000-00-00


OroMin HUMAN OTC DRUG Details:

Item DescriptionOroMin from Germiphene Corporation
LABELER NAME: Germiphene Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: .056; .054; .01(g/100g; g/100g; g/100g)
START MARKETING DATE: 2017-06-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61508-0200_51d8d5bd-babb-44c3-e054-00144ff88e88
PRODUCT NDC: 61508-0200
APPLICATION NUMBER:

Other SODIUM PHOSPHATE, MONOBASIC; CALCIUM CHLORIDE; SODIUM FLUORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Germiphene CorporationOroMin